Congratulations to the New York Stem Cell Foundation for Being Named Time Magazine’s #1 Medical Breakthough of 2011

It is great to see that stem cell research has made tremendous strides in 2011. Hamilton Thorne applauds our customer, the New York Stem Cell Foundation (NYSCF), for being named Time Magazine’s #1 Medical Breakthrough for 2011.

Here is an excerpt from the NYSCF’s press release, ” TIME magazine has designated research conducted in the laboratory of the New York Stem Cell Foundation (NYSCF) as the #1 Medical Breakthrough of the year.

TIME cited research led by NYSCF scientists Dieter Egli and Scott Noggle in which adult skin cells from patients with Type 1 diabetes were reprogrammed to the pluripotent state by combining the cells with unfertilized donor oocytes. The scientists then succeeded in differentiating the pluripotent cells into other cell types in the body, including insulin-producing beta cells that are lacking in persons with Type 1 diabetes.

The discovery has implications for treatments of many other diseases besides diabetes, since the cells Egli and Noggle created  contain the patient’s own DNA and would resist rejection by the patient’s immune system if transplanted as part of cell replacement therapy. NYSCF scientists are currently conducting further research needed to overcome a remaining obstacle before the cells can be considered for treatment purposes.

In the magazine’s online article, TIME health and medical writer Alice Park writes: “The process is promising because it can potentially yield stem cells – which may one day treat diseases such as spinal cord injury and Parkinson’s – that not only match their donor, but also obviate the need for an embryo.”

To read the full press release, click here

With 2011 being such an exicting year, we look forward to seeing what our prestigious customers have in store for the research world in 2012.

Posted in In the News, Research & Development, Uncategorized | Leave a comment

David Wolf Featured in PharmaVoice’s 2012 Preview Issue

Hamilton Thorne CEO David Wolf provides  insights on Research and Development trends in PharmaVoice’s November/December “2012 Preview” issue: http://viewer.zmags.com/publication/7e0af12c#/7e0af12c/42

CEO David Wolf Featured in November/December 2011 Issue

Posted in Corporate Communications, In the News, Research & Development | Leave a comment

FREE WEBINAR ON MAKING CLINICAL-GRADE STEM CELLS USING LASER TECHNOLOGY

Hamilton Thorne will be hosting an online Webinar titled, “Discover How to Make Clinical-Grade Stem Cells Using New Laser Technology.”  Registrants for the Webinar will be entered into a raffle to win an iPad 2. The winner will be announced at the end of the Webinar, so register today for your chance to win!  

Registration Page: https://www3.gotomeeting.com/register/882322638

  • Date and Time:

Thursday, September 29th at 1:00 PM EDT/10:00 AM PDT

  • Featured speakers:

Lily Reed, Senior Director Research Market, Business & Applications Development
Hamilton Thorne Inc. Title: Learn How Lasers, like the new Stiletto™, Can Save Researchers Valuable Time and Money for Stem Cell Colony Maintenance and Passaging. 

Dr. Jeffery Jones, PhD, HCLD (ABB), Director of the Derivation Laboratory, WiCell Research Institute. Title: Learn How Lasers, like the new Stiletto™, Can Save Researchers Valuable Time and Money for Stem Cell Colony Maintenance and Passaging.

  • Topics Include:
    • How automation can save hours of time and money from manually separating and removing unwanted cells  
    • How laser technologies can integrate into your current workflow
    • Technical features of XYClone™ with Staccato™ software, and the new Stiletto™ laser
      • Auto-scoring for colony passaging, uniform pattern or user-defined sections of size and shape
      • Non-Xenogentic inner cell mass definition of embryonic stem cells
      • Automated ablation of differentiated cells
      • Best practices and real examples of how to use this laser technology to meet the high-degree of quality necessary when treating and manipulating stem cell colonies.

 

Posted in Uncategorized | Leave a comment

The Future of Stem Cell Research

A live chat about The Future of Stem Cell Research just concluded on Science.org. The guest “speakers” were Amander Clark, PhD, a stem cell researcher at UCLA and Hank Greely, a professor at Stanford Law School.

The chat archive is available and may be viewed at http://news.sciencemag.org/sciencenow/2011/08/live-chat-the-future-of-stem-cel.html .

Posted in Educational Materials | Leave a comment

3 Reasons to Consider a Digital/Interactive Annual Report

It’s the end of the year and you are thinking about your upcoming annual report and how best to reflect the Company’s successes and milestones. The numbers can speak for themselves, but when engaging with a variety of audiences from investors, partners, customers, and employees, why not actually have your management team “speak” to them.   

Here are three reasons to consider a digital/interactive annual report:

1. Put a face on the management team and employees

  • When it comes down to investing in a company, you certainly look at their product lines and financials, but you are also investing in the people. Showcasing personalities and passion for the work will go a long way.  

2. Leverage multi-media

  •  Do you have a corporate video, broll, photos, employee testimonials, podcasts…why not use them for your annual report? Seeing employees in action is a great opportunity for outside stakeholders to understand how employees collaborate and interact with each other in the work environment.
  • If you do not have multi-media in-house, you should consider making room for it in your budget for 2011. There are cost-effective ways to commission quality multi-media projects that will have a high impact.

3. Make it interesting, and dare I say, Fun?

  • Pictures and video are great, but it can also come off as “talking heads” or static. Consider putting in something fun such as an interactive photo gallery where the user selects what and how they would like to view.
  • You can also consider something that viewers can manipulate and engage with that could make their viewing experience fun. Our report had a user propelled 360 degree rotating view of one of our flagship products.

Come see how we did it; view Hamilton Thorne’s Interactive 2010 Annual Report! 

 

Posted in Corporate Communications | 1 Comment

Why All Stem Cells Sources Should Be Considered in Regenerative Medicine

Despite many advances in scientific research for iPS cells, Nature published an article on May 13, 2011 citing that reprogrammed cells had triggered an immune reaction in mice. These findings were later reported in a New York Times article by Andy Pollack.

This latest set back for use of iPS cells in mice emphasizes once again the extreme urgency to create sensible regulations for use of embryonic stem cells in regenerative medicine. The removal of politics from medical research has never been more pressing. Not only have embryonic stem cells been used to create various exciting treatments now in FDA clinical trials, but in many countries, researchers do not have to operate under the cloud of uncertainty caused by wavering court rulings and US political pressures.

Any important research program takes years, but in the present legal climate, groups seeking funding will surely be reluctant to gamble on the future of their research and financial support for the people in their lab. In short, with limited use of embryonic stem cells, treatments for diseases such as Parkinson’s, Alzheimer’s, ALS, Macular degeneration and heart disease will only be further delayed. With a rapidly aging population, the cost of such delays is incalculable.

Posted in Corporate Communications, Executive Management, In the News | Tagged , , , , , , , , , , , , , | Leave a comment

Listen Up! CEO Meg Spencer Talks to MassDevice about Solving Today’s Most Challenging Life Science Problems in a Q & A Podcast

MassDevice       CEO Meg Spencer of Hamilton Thorne was featured  in an April 15th article and podcast on Mass Device. Click to hear the full podcast–Definitely worth a listen!

Hamilton Thorne CEO Meg Spencer

MassDevice asks Meg Spencer, CEO of Hamilton Thorne Ltd., how the company stays on the cutting edge of life science technology and its footprint in stem cells and regenerative medicine. Click here to read the article

Posted in Corporate Communications, In the News | Tagged , , , , , , , | Leave a comment

From the Tooth Fairy to Stem Cell Collection; Could Your Child’s Baby Teeth Save Lives?

As a Mother of a 5-year-old son, I will soon go through a parent’s rite of passage of my child losing his first baby tooth. Usually the only concern would be how much money the “tooth fairy” is going to leave him under his pillow, but maybe now I should consider donating his baby teeth to a stem cell bank. Believe it or not, this is a growing trend despite medical science not quite being able to deliver on the promise (just yet).

Here is a recent article from the Miami Herald discussing this topic, “South Florida and around the world, dentists are extracting baby teeth, wisdom teeth and even healthy adult teeth, and researchers are spinning out stem cells that they believe can be used to regrow lost teeth, someday even to repair damaged bones, hearts, pancreases, muscles and brains.”

In addition to the Miami Herald, there have been several other articles dedicated to this topic of late, as well as a feature news story even back in 2008 from GMA/ABC NewsCould Baby Teeth Stem Cells Save Your Child?

So should we as parents start collecting our children’s baby teeth in order to help them fight potential life-threatening illnesses? Or in the case of ourselves, should adults have their own teeth extracted for future treatments for our own possible diseases? From the current available data, it appears that the answer to that question may be a bit premature.

According to the Miami Herald, “There are concerns. It’s expensive, costing $590 upfront plus $100 a year to store the stem cells from up to four teeth for up to 20 years. It’s speculative, with the first FDA-approved practical use of such stem cells years away.”

With that said, there have been numerous breakthroughs in 2010 in both stem cell research and regenerative medicine. The New York Times reported on the remarkable year that the industry has had in 2010, with all signs showing that the next few years will be even more exciting. So maybe banking our children’s baby teeth might be a good alternative for stem cell collection if the science continues to move full speed ahead.

Which brings me back to my original concern, just how much do you pay your child for their first lost tooth? My parents used to give me a quarter, but should I account for inflation? And if so, how would you go about calculating that amount? I bet there is an app for that, time to search the Droid store!   

baby teeth, Courtesy of ABC News 
ABC/Getty

Posted in Corporate Communications, In the News | Tagged , , , , , , | 1 Comment

CEO Meg Spencer Thinks “Outside the Box” According to the Boston Business Journal

CEO Meg Spencer of Hamilton Thorne was asked by Julie Donnelly of the Boston Business Journal to discuss a variety of topics from “What is a good day for you” to “If you could have dinner with 3 people, who would they be?”

Read the full article here.

CEO Meg Spencer

Meg Spencer Holds a New World of Research Possibilities in Her Hand

Posted in Corporate Communications | Tagged , , , , , , , , | Leave a comment

New induced stem cells may unmask cancer at earliest stage

From ScienceDaily (Feb. 4, 2011) — By coaxing healthy and diseased human bone marrow to become embryonic-like stem cells, a team of Wisconsin scientists has laid the groundwork for observing the onset of the blood cancer leukemia in the laboratory dish.

“This is the first successful reprogramming of blood cells obtained from a patient with leukemia,” says University of Wisconsin-Madison stem cell researcher Igor Slukvin, who directed a study aimed at generating all-purpose stem cells from bone marrow and umbilical cord blood. “We were able to turn the diseased cells back into pluripotent stem cells. This is important because it provides a new model for the study of cancer cells.”

The research was reported Feb. 4 in the journal Blood by Slukvin and colleagues from the WiCell Research Institute and the Morgridge Institute for Research, private research centers in Madison.

Read the complete news report: New induced stem cells may unmask cancer at earliest stage.

Posted in In the News | Tagged , , , | Leave a comment